Search Results - "Fructuoso, Ferran José García"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
  2. 2

    A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of Tildrakizumab Efficacy and Safety in Patients With Active Ankylosing Spondylitis by Peters, Eric, Chou, Richard C., Rozzo, Stephen J., Yao, Siu-Long, Fructuoso, Ferran José García

    Published in Journal of clinical rheumatology (01-08-2023)
    “…Tildrakizumab is an anti-interleukin-23p19 monoclonal antibody approved to treat moderate to severe plaque psoriasis. This study evaluated the efficacy and…”
    Get full text
    Journal Article
  3. 3